Sbc Medical Group Holdings Inc (SBC) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Sbc Medical Group Holdings Inc (SBC) stock forecast summary
Our AI ranks Sbc Medical Group Holdings Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Sbc Medical Group Holdings Inc is a small-cap company with a market capitalization of $547M. It ranks number 2 by market capitalization among the 5 Services-Offices & Clinics of Doctors of Medicine issuers in our coverage with a current forecast. Its Net Margin of 28.0% is the highest of the 8 peers that report one. Its Current Ratio of 3.31x is the highest of the 8 peers that report one.
A per-ticker accuracy statistic for SBC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, SBC included.
Follow SBC freeSBC price chart and AI forecast
How SBC ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Sbc Medical Group Holdings Inc (SBC) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Offices & Clinics of Doctors of Medicine peers listed below that report each metric.
Valuation & Market
| Metric | SBC | Rank |
|---|---|---|
| Market Cap | $547M | 2/5 |
| P/E Ratio | 11.16x | – |
| P/B Ratio | 2.07x | – |
| EPS | $0.58 | – |
| Book Value/Share | $2.57 | – |
| Revenue/Share | $1.70 | – |
| FCF/Share | $0.60 | – |
Profitability & Margins
| Metric | SBC | Rank |
|---|---|---|
| ROE | 18.6% | 1/6 |
| ROA | 12.1% | 1/8 |
| ROIC | 19.9% | 2/8 |
| Gross Margin | 71.8% | 2/6 |
| Operating Margin | 37.3% | 1/8 |
| Net Margin | 28.0% | 1/8 |
| EBT Margin | 43.1% | 1/8 |
| Tax Rate | 33.5% | – |
Financial Health
| Metric | SBC | Rank |
|---|---|---|
| Current Ratio | 3.31x | 1/8 |
| Quick Ratio | 3.27x | 1/6 |
| D/E Ratio | 0.48x | 6/6 |
| Financial Leverage | 1.54x | 6/6 |
| Interest Coverage | 150.3x | 2/8 |
| Working Capital | $181M | 1/8 |
Cash Flow
| Metric | SBC | Rank |
|---|---|---|
| Operating Cash Flow | $63M | 3/8 |
| Free Cash Flow | $62M | 2/6 |
| Capital Spending | -$1M | 2/6 |
| OCF Growth YoY | 316.9% | 1/5 |
| FCF Growth YoY | 417.3% | – |
| FCF/Sales | 35.3% | 1/6 |
| CapEx/Sales | 0.6% | 4/6 |
Operational Efficiency
| Metric | SBC | Rank |
|---|---|---|
| Asset Turnover | 0.43x | 7/7 |
| Inventory Turnover | 16.6x | – |
| Fixed Assets Turnover | 23.6x | 5/6 |
| Days Inventory | 22 days | – |
Income Statement
| Metric | SBC | Rank |
|---|---|---|
| Total Revenue | $175M | 4/7 |
| Operating Income | $65M | 1/8 |
| Net Income | $49M | 1/8 |
| SG&A Expense | $60M | 5/7 |
| Cost of Goods Sold | $49M | 4/6 |
Dividend & Shareholder Information
| Metric | SBC | Rank |
|---|---|---|
| Shares Outstanding | 103M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $259M | 63.8% of assets |
| Cash & Short-term Investments | $184M | 45.3% of assets |
| Inventory | $3M | 0.7% of assets |
| Total Liabilities | $127M | 31.2% of assets |
SBC quarterly financials and insider trading
Sbc Medical Group Holdings Inc (SBC) industry peers
Companies classified under the same SEC industry code as Sbc Medical Group Holdings Inc (Services-Offices & Clinics of Doctors of Medicine): 8 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| SBC Sbc Medical Group Holdings Inc | ▼ | $547M |
| TDOC Teladoc Health, Inc. | ▶ | $1.09B |
| LFMD Lifemd, Inc. | ▲ | $119M |
| AIRS Airsculpt Technologies, Inc. | ▲ | $117M |
| HLYK Healthlynked Corp | ▲ | $6M |
| CDIX Cardiff Lexington Corp | ▼ | N/A |
| HIMS Hims & Hers Health, Inc. | ▶ | N/A |
| STLN Starling Oncology, Inc. | ▲ | N/A |
Where SBC sits on the market map
Sbc Medical Group Holdings Inc (SBC) stock news
Loading...
Sbc Medical Group Holdings Inc (SBC) stock forecast FAQ
What is the Sbc Medical Group Holdings Inc (SBC) stock forecast?
Our AI ranks Sbc Medical Group Holdings Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Sbc Medical Group Holdings Inc stock predictions?
A per-ticker accuracy statistic for SBC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Sbc Medical Group Holdings Inc forecasts updated?
Sbc Medical Group Holdings Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Sbc Medical Group Holdings Inc's industry peers?
8 issuers in our coverage, SBC included, share the SEC industry code Services-Offices & Clinics of Doctors of Medicine. The largest are: Teladoc Health, Inc. (TDOC), Lifemd, Inc. (LFMD), Airsculpt Technologies, Inc. (AIRS), Healthlynked Corp (HLYK), Cardiff Lexington Corp (CDIX), Hims & Hers Health, Inc. (HIMS).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.